| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.19 | 9e-05 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.17 | 0.0008 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.14 | 0.007 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.077 | 0.1 |